Nido Biosciences

Developer of therapeutics for neurological disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2018 groups26 employees language nidobio.com

Registered entities

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 252 times.

YearFilings
20222
20233
20242
20254

Investor mix

8 investors on record; lead investors include Bioluminescence Ventures, 5AM Ventures, Abingworth, Bessemer Venture Partners.

Investor typeCountShare
Venture capital788%
Other / undisclosed113%
Coming soon